Hormone Pellet Therapy Training for Dentists

Hormone pellets are small, rice-grain-sized cylinders of compressed bioidentical hormones (typically testosterone or estradiol) that are inserted subcutaneously in a brief in-office procedure. Once implanted, the pellets dissolve gradually over three to six months, delivering a steady, consistent dose of hormones that mimics the body's natural release patterns. This avoids the peaks and troughs associated with injections, creams, and oral hormone preparations.

Licensed healthcare professionals with scope of practice that includes minor procedures can perform pellet insertions after completing this certification. This typically includes physicians (MD/DO), nurse practitioners, physician assistants, and in some states, chiropractors and dentists with appropriate scope. Your ability to perform the procedure and prescribe hormones depends on your professional license and state regulations. Empire's certification documents your procedural competency.

Pellet therapy offers several advantages over injections, creams, patches, and oral hormones: more consistent serum levels without peaks and troughs, superior patient compliance (no daily or weekly self-administration), longer dosing intervals (3-6 months), and avoidance of transference risk associated with topical preparations. The course covers comparative analysis of all delivery methods to help you guide patients in selecting the best approach for their individual needs.

The course covers comprehensive monitoring panels including total and free testosterone, estradiol, sex hormone-binding globulin (SHBG), complete blood count, liver function, lipid panel, PSA for men, and other markers specific to hormone optimization. You will learn the appropriate timing for pre- and post-insertion lab draws, target therapeutic ranges, and how to adjust dosing based on both laboratory values and clinical symptom response.

Hormone pellet therapy generates significant per-procedure revenue with pellet insertion fees typically ranging from $300-$500 for women and $600-$900 for men, with re-insertion every three to six months. A practice managing 100-200 active hormone patients can generate $200K-$500K+ in annual revenue from pellet therapy alone. The recurring nature of treatment creates a predictable, growing revenue base as your patient panel expands.

Pellet insertions require a trocar insertion kit, local anesthetic, sterile draping supplies, wound closure strips, and the hormone pellets themselves sourced from an FDA-registered compounding pharmacy. The total per-procedure supply cost is minimal relative to the procedure fee. The course includes detailed equipment lists, vendor recommendations, and guidance on establishing compounding pharmacy relationships for reliable pellet sourcing.

Hormone decline significantly impacts oral health through multiple pathways: estrogen deficiency reduces bone density (affecting implant success and periodontal support), testosterone decline impairs tissue healing, hormonal changes alter salivary composition and flow (increasing caries risk), and menopause-related dry mouth accelerates periodontal disease. Understanding these connections improves your diagnostic accuracy and treatment planning for hormone-affected patients.

Dental scope for hormone services varies by state. Some dentists offer BHRT through separate clinical entities or expanded practice models. The course provides the clinical knowledge and procedural training; we recommend consulting your state dental board regarding appropriate practice structures. Your surgical skills and patient management experience provide an excellent clinical foundation for this procedural service.

Hormone pellet insertions generate $300–$500 for women and $600–$900 for men, with patients returning every 3–6 months. A panel of 50–100 hormone patients creates $100K–$300K+ in annual recurring revenue — entirely cash-pay and independent of dental insurance. This revenue stream provides financial diversification and stability that complements episodic dental treatment income.

In most states, dentists are authorized to administer botulinum toxin and dermal filler injections within the head, neck, and associated structures. Some states define this scope broadly to include cosmetic applications, while others limit dental injectable use to therapeutic and functional purposes. Empire recommends confirming your state dental board's specific guidelines. Our training provides the clinical certification recognized by dental boards nationwide.

Dentists have superior knowledge of facial anatomy, nerve pathways, and injection techniques compared to most other healthcare professionals entering aesthetics. Your daily experience with local anesthesia, precise needle placement, and patient management in the facial region gives you a significant head start. Empire's course builds on these existing competencies to add aesthetic-specific protocols, product knowledge, and treatment planning skills.

Dental practices that add aesthetic injectable services typically generate $100K-$300K+ in additional annual revenue, often from their existing patient base. Botox and filler treatments have high profit margins, create recurring revenue through maintenance appointments, and attract new patients who become dental patients as well. The crossover appeal is significant — patients who trust you with their smile naturally trust you with their facial aesthetics.